As AI accelerates recombinant protein and antibody discovery for therapeutic and diagnostic development, access to well-characterized target proteins is essential for evaluating AI-designed molecules. Sino Biological, Inc., a global biotechnology company specializing in recombinant proteins, antibodies, and CRO services, introduces two dedicated target protein collections for AI-driven discovery: AI-trusted proteins and AI-qualified proteins.

Image Credit: Sino Biological Inc.
Together, these collections offer researchers access to target proteins with demonstrated use in AI research, experimentally characterized binding activity, and specialized formats to support diverse AI-driven validation.
Two collections. Two ways to support AI validation.
AI-trusted proteins – Proven in AI research
AI-Trusted Proteins have been used in AI-focused company validation projects, with some proteins featured in published research. This collection currently covers 600+ targets and 960+ individual proteins, with available characterization data for each protein potentially including SPR, BLI, ELISA, cell-based activity assays, SEC-HPLC, and SEC-MALS analyzes.
AI-qualified proteins – Characterized for AI validation
AI-qualified proteins feature experimentally characterized target binding activity, including SPR/BLI validation data, as well as specialized formats such as biotinylated proteins for AI-driven research. With 680+ targets and 1,700+ individual proteins, this collection provides researchers with a broad selection of characterized target proteins for evaluating AI-designed molecules.
The 4S system: Building confidence in target protein resources
Supporting these collections is Sino Biological's 4S System – scale, scope, speed, and supply, designed to provide the resource breadth, production capabilities, and supply reliability required by AI-driven discovery.
- Scale: More than 11,000 recombinant target proteins, including over 1,200 biotinylated proteins.
- Scope: Broad coverage of membrane, extracellular, and intracellular proteins, as well as mutants and diverse protein formats.
- Speed: Rapid, scalable production, efficient order processing, and local inventory and delivery capabilities.
- Supply: Lot-to-lot consistency, multi-lot availability, and reliable long-term supply.
Together, the 4S system helps researchers access a broad range of target proteins while supporting consistent experimental needs and ongoing AI research programs.
Sino Biological has also developed a therapeutic target directory covering 12 therapeutic areas and more than 100 diseases, enabling researchers to explore relevant targets by therapeutic area or disease.
4RISE™: Connecting target resources with end-to-end AI validation
Target proteins are a critical part of experimental validation. As a key resource within Sino Biological's 4RISE™ AI Lab Validation Solution, the AI-focused target protein library works alongside high-throughput protein expression, binding and affinity characterization, developability assessment, and functional validation.
Built around four strengths – Rapid, In-Depth, Seamless, and Empirical – 4RISE™ provides integrated wet-lab support to help researchers advance AI-designed molecules from computational predictions to experimental evidence.
AI-driven discovery depends on reliable experimental resources to evaluate designed molecules and guide subsequent research decisions, By combining AI-trusted and AI-qualified target proteins with our 4S System, we aim to provide researchers with well-characterized target resources, broad coverage, and dependable supply to support AI-driven protein and antibody discovery."
Dr. Rob Burgess, Chief Business Officer, Sino Biological US